Corebridge Financial »

Denali Therapeutics shares owned by Corebridge Financial

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Corebridge Financial from 13F filings

Historical chart of Corebridge Financial investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Corebridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Corebridge Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $828k 61k 13.60
2024-12-31 $1.3M 62k 20.38

More positions owned by Corebridge Financial

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Blackrock Etf Trust Ii Ishares Aaa Clo (CLOA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Nrg Energy Com New (NRG)

View all positions for Corebridge Financial

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics